Drug interactions and the evolution of antibiotic resistance
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Large-scale, systems biology approaches now allow us to systematically map synergistic and antagonistic interactions between drugs. Consequently, drug antagonism is emerging as a powerful tool to study biological function and relatedness between cellular components as well as to uncover mechanisms of drug action. Furthermore, theoretical models and new experiments suggest that antagonistic interactions between antibiotics can counteract the evolution of drug resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the interactions can be highly dosedependent”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotics in Laboratory Medicine.
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-93-4-653_4 · Cited by 2,779
THE TOXICITY OF POISONS APPLIED JOINTLY1
BLISS, C. I. (1939) · Annals of Applied Biology · doi:10.1111/j.1744-7348.1939.tb06990.x · Cited by 2,419
Systematic Genetic Analysis with Ordered Arrays of Yeast Deletion Mutants
Tong, A. H. Y., Evangelista, M., Parsons, A. B., Xu, H., Bader, G. D., Pagé, N., Robinson, M., Raghibizadeh, S., Hogue, C. W. V., Bussey, H., et al. (2001) · Science · doi:10.1126/science.1065810 · Cited by 2,138
Global Mapping of the Yeast Genetic Interaction Network
Tong, A. H. Y., Lesage, G., Bader, G. D., Ding, H., Xu, H., Xin, X., Young, J., Berriz, G. F., Brost, R. L., Chang, M., et al. (2004) · Science · doi:10.1126/science.1091317 · Cited by 2,095
The search for synergy: a critical review from a response surface perspective.
Greco, W. R., Bravo, G., & Parsons, J. C. (1995) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06847-4 · Cited by 1,434
Schuldiner, M., Collins, S. R., Thompson, N. J., Denic, V., Bhamidipati, A., Punna, T., Ihmels, J., Andrews, B., Boone, C., Greenblatt, J. F., et al. (2005) · Cell · doi:10.1016/j.cell.2005.08.031 · Cited by 870
Collins, S. R., Miller, K. M., Maas, N. L., Roguev, A., Fillingham, J., Chu, C. S., Schuldiner, M., Gebbia, M., Recht, J., Shales, M., et al. (2007) · Nature · doi:10.1038/nature05649 · Cited by 869
Modular epistasis in yeast metabolism
Segrè, D., DeLuna, A., Church, G. M., & Kishony, R. (2005) · Nature Genetics · doi:10.1038/ng1489 · Cited by 575
Self-citationEpistasis and the Evolutionary Process
Hurst, L. D. (2000) · Heredity · doi:10.1046/j.1365-2540.2000.0846b.x · Cited by 563
A DNA Integrity Network in the Yeast Saccharomyces cerevisiae
Pan, X., Ye, P., Yuan, D. S., Wang, X., Bader, J. S., & Boeke, J. D. (2006) · Cell · doi:10.1016/j.cell.2005.12.036 · Cited by 537 · cited 1×
“Systematic screens for synergy between double gene knockouts have been successfully used to understand biological systems in bacteria and yeas”
A comprehensive strategy enabling high-resolution functional analysis of the yeast genome
Breslow, D. K., Cameron, D. M., Collins, S. R., Schuldiner, M., Stewart-Ornstein, J., Newman, H. W., Braun, S., Madhani, H. D., Krogan, N. J., & Weissman, J. S. (2008) · Nature Methods · doi:10.1038/nmeth.1234 · Cited by 534 · cited 1×
“or on measuring direct competition between mutants and reference strains using differential fluorescence labellin”
Lehner, B., Crombie, C., Tischler, J., Fortunato, A., & Fraser, A. G. (2006) · Nature Genetics · doi:10.1038/ng1844 · Cited by 502 · cited 1×
“Systematic screens for synergy between double gene knockouts have been successfully used to understand biological systems in bacteria and yeas”
Mani, R., St.Onge, R. P., Hartman, J. L., Giaever, G., & Roth, F. P. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0712255105 · Cited by 473
Antibiotic interactions that select against resistance
Chait, R., Craney, A., & Kishony, R. (2007) · Nature · doi:10.1038/nature05685 · Cited by 439 · cited 1×
“Recent studies have suggested that antagonistic drug pairs can slow down and potentially even reverse the evolution of drug resistanc”
Self-citationThe mutant selection window and antimicrobial resistance
Drlica, K. (2003) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkg269 · Cited by 437 · cited 1×
“, a region termed the mutant selection window (MSW”
Epistasis and the Evolutionary Process
Wolf, J. B., Brodie, E. D., & Wade, M. J. (2000) · Cited by 434
Eagle, H., & Musselman, A. D. (1948) · Journal of Experimental Medicine · doi:10.1084/jem.88.1.99 · Cited by 375 · cited 1×
“Although the specific mechanistic reasons for this effect are not understood, it is worth mentioning a different, yet potentially related, phenomenon called the Eagle effec”
Conservation and Rewiring of Functional Modules Revealed by an Epistasis Map in Fission Yeast
Roguev, A., Bandyopadhyay, S., Zofall, M., Zhang, K., Fischer, T., Collins, S. R., Qu, H., Shales, M., Park, H.-O., Hayles, J., et al. (2008) · Science · doi:10.1126/science.1162609 · Cited by 352
Functional classification of drugs by properties of their pairwise interactions
Yeh, P., Tschumi, A. I., & Kishony, R. (2006) · Nature Genetics · doi:10.1038/ng1755 · Cited by 350 · cited 1×
“These ideas and methodologies have been used to classify antibiotics in a pair-wise interaction networ”
Self-citationFrankel, W. N., & Schork, N. J. (1996) · Nature Genetics · doi:10.1038/ng1296-371 · Cited by 316
Blondeau, J. M., Zhao, X., Hansen, G., & Drlica, K. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.2.433-438.2001 · Cited by 314
A strategy for extracting and analyzing large-scale quantitative epistatic interaction data
Collins, S. R., Schuldiner, M., Krogan, N. J., & Weissman, J. S. (2006) · Genome Biology · doi:10.1186/gb-2006-7-7-r63 · Cited by 310
Systematic pathway analysis using high-resolution fitness profiling of combinatorial gene deletions
Onge, R. P. S., Mani, R., Oh, J., Proctor, M., Fung, E., Davis, R. W., Nislow, C., Roth, F. P., & Giaever, G. (2007) · Nature Genetics · doi:10.1038/ng1948 · Cited by 309
Accelerated evolution of resistance in multidrug environments
Hegreness, M., Shoresh, N., Damian, D., Hartl, D., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805965105 · Cited by 300 · cited 1×
“Recent studies have suggested that antagonistic drug pairs can slow down and potentially even reverse the evolution of drug resistanc”
Self-citationDong, Y., Zhao, X., Domagala, J., & Drlica, K. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.7.1756 · Cited by 278
Chemical combination effects predict connectivity in biological systems
Lehár, J., Zimmermann, G. R., Krueger, A. S., Molnar, R. A., Ledell, J. T., Heilbut, A. M., Short, G. F., Giusti, L. C., Nolan, G. P., Magid, O. A., et al. (2007) · Molecular Systems Biology · doi:10.1038/msb4100116 · Cited by 275
The Language of Gene Interaction
Phillips, P. C. (1998) · Genetics · doi:10.1093/genetics/149.3.1167 · Cited by 273
LEPPER, M. H. (1951) · A.M.A. Archives of Internal Medicine · doi:10.1001/archinte.1951.03810100073006 · Cited by 254
High-throughput, quantitative analyses of genetic interactions in E. coli
Typas, A., Nichols, R. J., Siegele, D. A., Shales, M., Collins, S. R., Lim, B., Braberg, H., Yamamoto, N., Takeuchi, R., Wanner, B. L., et al. (2008) · Nature Methods · doi:10.1038/nmeth.1240 · Cited by 239
The population dynamics of antimicrobial chemotherapy
Lipsitch, M., & Levin, B. R. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.363 · Cited by 237
The contribution of epistasis to the architecture of fitness in an RNA virus
Sanjuán, R., Moya, A., & Elena, S. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0404125101 · Cited by 233
Die quantitativen Probleme der Pharmakologie
Loewe, S. (1928) · Ergebnisse der Physiologie · doi:10.1007/bf02322290 · Cited by 229
Treatment of antiretroviral-drug-resistant HIV-1 infection
Deeks, S. G. (2003) · The Lancet · doi:10.1016/s0140-6736(03)15022-2 · Cited by 219
Drug interactions modulate the potential for evolution of resistance
Michel, J.-B., Yeh, P. J., Chait, R., Moellering, R. C., & Kishony, R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800944105 · Cited by 215 · cited 1×
“Recent studies have suggested that antagonistic drug pairs can slow down and potentially even reverse the evolution of drug resistanc”
Self-citationFirsov, A. A., Vostrov, S. N., Lubenko, I. Y., Drlica, K., Portnoy, Y. A., & Zinner, S. H. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.5.1604-1613.2003 · Cited by 215 · cited 1×
“It is worth noting, however, that in addition to the time within the MS”
Zhao, X., & Drlica, K. (2002) · The Journal of Infectious Diseases · doi:10.1086/338571 · Cited by 210
Exposing the fitness contribution of duplicated genes
DeLuna, A., Vetsigian, K., Shoresh, N., Hegreness, M., Colón-González, M., Chao, S., & Kishony, R. (2008) · Nature Genetics · doi:10.1038/ng.123 · Cited by 182 · cited 1×
“or on measuring direct competition between mutants and reference strains using differential fluorescence labellin”
Self-citationCombination Therapy for Malaria: The Way Forward?
Nosten, F. H., & Brasseur, P. (2002) · Drugs · doi:10.2165/00003495-200262090-00003 · Cited by 173
Global synthetic-lethality analysis and yeast functional profiling
Ooi, S. L., Pan, X., Peyser, B. D., Ye, P., Meluh, P. B., Yuan, D. S., Irizarry, R. A., Bader, J. S., Spencer, F. A., & Boeke, J. D. (2006) · Trends in Genetics · doi:10.1016/j.tig.2005.11.003 · Cited by 164
High-throughput genetic interaction mapping in the fission yeast Schizosaccharomyces pombe
Roguev, A., Wirén, M., Weissman, J. S., & Krogan, N. J. (2007) · Nature Methods · doi:10.1038/nmeth1098 · Cited by 159
Functional Maps of Protein Complexes from Quantitative Genetic Interaction Data
Bandyopadhyay, S., Kelley, R., Krogan, N. J., & Ideker, T. (2008) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000065 · Cited by 141 · cited 1×
“or between two components of the same protein comple”
Environmental stresses can alleviate the average deleterious effect of mutations
Kishony, R., & Leibler, S. (2003) · Journal of Biology · doi:10.1186/1475-4924-2-14 · Cited by 139
Self-citationEvolutionary plasticity of genetic interaction networks
Tischler, J., Lehner, B., & Fraser, A. G. (2008) · Nature Genetics · doi:10.1038/ng.114 · Cited by 137 · cited 1×
“Systematic screens for synergy between double gene knockouts have been successfully used to understand biological systems in bacteria and yeas”
Epistatic buffering of fitness loss in yeast double deletion strains
Jasnos, L., & Korona, R. (2007) · Nature Genetics · doi:10.1038/ng1986 · Cited by 137
Gene function prediction from congruent synthetic lethal interactions in yeast
Ye, P., Peyser, B. D., Pan, X., Boeke, J. D., Spencer, F. A., & Bader, J. S. (2005) · Molecular Systems Biology · doi:10.1038/msb4100034 · Cited by 136
Combination therapy of malaria
Cn, S. (1969) · JAMA · doi:10.1001/jama.208.4.695b · Cited by 133
Dong, Y., Zhao, X., Kreiswirth, B. N., & Drlica, K. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2581-2584.2000 · Cited by 128
The mode of action of 4-quinolones and possible mechanisms of resistance
Smith, J. T. (1986) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/18.supplement_d.21 · Cited by 125
Derivation of genetic interaction networks from quantitative phenotype data
Drees, B. L., Thorsson, V., Carter, G. W., Rives, A. W., Raymond, M. Z., Avila-Campillo, I., Shannon, P., & Galitski, T. (2005) · Genome Biology · doi:10.1186/gb-2005-6-4-r38 · Cited by 121
Metzler, K., Hansen, G. M., Hedlin, P. D., Harding, E., Drlica, K., & Blondeau, J. M. (2004) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2004.02.021 · Cited by 114
Strategies to minimize the development of antibiotic resistance.
Baquero, F., & Negri, M. C. (1997) · PubMed · Cited by 95
Lewin, C. S., Morrissey, I., & Smith, J. T. (1991) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/bf01966996 · Cited by 92 · cited 1×
“This phenomenon is most pronounced when DNA synthesis inhibitors, such as ciprofloxacin, are use”
Marcusson, L. L., Olofsson, S. K., Lindgren, P. K., Cars, O., & Hughes, D. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki136 · Cited by 85
Lecture on the Antagonism between the Actions of Active Substances
Fraser, T. R. (1872) · BMJ · doi:10.1136/bmj.2.618.485 · Cited by 79
Rodríguez-Martínez, J. M., Velasco, C., García, I., Cano, M. E., Martínez-Martínez, L., & Pascual, A. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01444-06 · Cited by 76
Antibiotics in Laboratory Medicine
Weldon-Linne, C. M. (1986) · JAMA · doi:10.1001/jama.1986.03370230115043 · Cited by 68
Zhanel, G. G., Mayer, M. L., Laing, N. M., & Adam, H. J. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01620-05 · Cited by 50
Networks from drug–drug surfaces
Yeh, P. J., & Kishony, R. (2007) · Molecular Systems Biology · doi:10.1038/msb4100133 · Cited by 42 · cited 1×
“The richness of the dose-by-dose interaction pattern contains valuable information on the underlying connectivity between the molecular targets of two drug”
Self-citationLi, X., Mariano, N., Rahal, J. J., Urban, C. M., & Drlica, K. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.11.4460-4462.2004 · Cited by 41
Linde, H. ‐. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh036 · Cited by 40
Resistance to Quinolones in Gram-Negative Microorganisms: Mechanisms and Prevention
Baquero, F. (1990) · European Urology · doi:10.1159/000464084 · Cited by 40
Blagosklonny, M. V. (1999) · Leukemia · doi:10.1038/sj.leu.2401623 · Cited by 39
Firsov, A. A., Lubenko, I. Y., Golikova, M. V., Strukova, E. N., & Zinner, S. H. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01371-07 · Cited by 37
THE ROLE OF BACTERIAL RESISTANCE IN ANTIBIOTIC SYNERGISM AND ANTAGONISM
Klein, M., & Schorr, S. E. (1953) · Journal of Bacteriology · doi:10.1128/jb.65.4.454-465.1953 · Cited by 31
Mutant prevention concentrations of ciprofloxacin and enrofloxacin for Salmonella enterica
Randall, L. P., Cooles, S. W., Piddock, L. J. V., & Woodward, M. J. (2004) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkh360 · Cited by 31
The Centenary of the One-Gene One-Enzyme Hypothesis
Hickman, M. J., & Cairns, J. (2003) · Genetics · doi:10.1093/genetics/163.3.839 · Cited by 23
INFECTIOUS DISEASES: PROBLEMS OF ANTIMICROBIAL THERAPY
Jawetz, E. (1954) · Annual Review of Medicine · doi:10.1146/annurev.me.05.020154.000245 · Cited by 17 · cited 1×
“Many factors affect the success of clinical treatments, including pharmacokinetics, heterogeneous drug concentrations, horizontal gene transfer, interactions with other microbial species and host interaction”
Meluh, P. B., Pan, X., Yuan, D., Tiffany, C. W., Chen, O., Sookhai-Mahadeo, S., Wang, X., Peyser, B. D., Irizarry, R. A., Spencer, F. A., et al. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-321-9_15 · Cited by 11
Cited by
Origins and evolution of antibiotic resistance
Davies, J., & Davies, D. (2010) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00016-10 · Cited by 5,784
“Is it possible that older and/or unused (or even discarded) antibiotics might be rehabilitated for “last-resort” use in rational combinations to overcome multidrug-resistant bacterial infections, as some studies have suggested (152)? Many strategies for avoiding, inhibiting, or bypassing resistance mechanisms in patho…”
BackgroundHow antibiotics kill bacteria: from targets to networks
Kohanski, M. A., Dwyer, D. J., & Collins, J. J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2333 · Cited by 2,258
Antibiotic resistance in microbes: History, mechanisms, therapeutic strategies and future prospects
Uddin, T. M., Chakraborty, A. J., Khusro, A., Zidan, B. R. M., Mitra, S., Emran, T. B., Dhama, K., Ripon, M. K. H., Gajdács, M., Sahibzada, M. U. K., et al. (2021) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2021.10.020 · Cited by 1,311
Antibiotic resistance: The challenges and some emerging strategies for tackling a global menace
Chinemerem Nwobodo, D., Ugwu, M. C., Oliseloke Anie, C., Al‐Ouqaili, M. T. S., Chinedu Ikem, J., Victor Chigozie, U., & Saki, M. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24655 · Cited by 985
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection
Toprak, E., Veres, A., Michel, J.-B., Chait, R., Hartl, D. L., & Kishony, R. (2012) · Nature Genetics · doi:10.1038/ng.1034 · Cited by 764
Self-citation
Metadata
- Authors
- Yeh, P. J., Hegreness, M. J., Aiden, A. P., & Kishony, R.
- Affiliations
- Harvard University (US)
- Broad Institute (US)
- Corresponding author
- Kishony, Roy
- Venue
- Nature Reviews Microbiology
- Published
- 2009-06
- Volume
- 7
- Issue
- 6
- Pages
- 460-466
- ISSN
- 1740-1526 (ISSN-L)
- 1740-1534
- PMC
- PMC2855488
- OpenAlex
- W2115076532
- Cited by
- 350
- References
- 68
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 23 · 2023: 29 · 2022: 22 · 2021: 27 · 2020: 14 · 2019: 23 · 2018: 22 · 2017: 29 · 2016: 23 · 2015: 16 · 2014: 31 · 2013: 20 · 2012: 13
- FWCI
- 0.72
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Microbiology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation
- National Institutes of Health
- National Defense Science and Engineering Graduate
- National Institute of General Medical Sciences (R01GM081617)
- Topics
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Evolution and Genetic Dynamics
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Keywords
- drug interactions, antibiotic resistance, drug antagonism, drug synergy, systems biology, mechanisms of drug action, resistance evolution
- MeSH terms
- Drug Antagonism, Drug Interactions, Drug Resistance, Microbial, Drug Synergism, Models, Theoretical, Signal Transduction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.